Literature DB >> 16530009

Streptococcus pneumoniae induces mast cell degranulation.

Giovanna Barbuti1, Monica Moschioni, Stefano Censini, Antonello Covacci, Cesare Montecucco, Pasqualina Montemurro.   

Abstract

Streptococcus pneumoniae colonizes the nasopharynx of healthy human carriers, but occasionally can spread in the body causing severe diseases. The mucosa of the respiratory tract is enriched in mast cells, key players of the innate immune response. Here, we report on the interaction of various strains of S. pneumoniae with the mast cell line RBL-2H3. Live, but not heat-killed, bacteria were found to induce mast cell degranulation in a dose- and time-dependent manner, only partially controlled by cytosolic calcium, with no production of TNF-alpha and IL-6. Non-encapsulated pneumococcal strains exhibited different potencies in triggering mast cells. We propose here that the induction of mast cell degranulation by pneumococcal factors not accompanied by the production of pro-inflammatory cytokines may be a specific strategy elaborated by this bacterium to promote its own spreading from the respiratory mucosa into the environment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16530009     DOI: 10.1016/j.ijmm.2005.11.009

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  10 in total

1.  Infection of mast cells with live streptococci causes a toll-like receptor 2- and cell-cell contact-dependent cytokine and chemokine response.

Authors:  Elin Rönnberg; Bengt Guss; Gunnar Pejler
Journal:  Infect Immun       Date:  2009-11-23       Impact factor: 3.441

Review 2.  The impact of bacterial infection on mast cell degranulation.

Authors:  Jordan Wesolowski; Fabienne Paumet
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

3.  Escherichia coli exposure inhibits exocytic SNARE-mediated membrane fusion in mast cells.

Authors:  Jordan Wesolowski; Fabienne Paumet
Journal:  Traffic       Date:  2014-03-07       Impact factor: 6.215

Review 4.  Mast cells: multitalented facilitators of protection against bacterial pathogens.

Authors:  Nikita H Trivedi; M Neal Guentzel; Annette R Rodriguez; Jieh-Juen Yu; Thomas G Forsthuber; Bernard P Arulanandam
Journal:  Expert Rev Clin Immunol       Date:  2013-02       Impact factor: 4.473

Review 5.  Diverse exocytic pathways for mast cell mediators.

Authors:  Hao Xu; Na-Ryum Bin; Shuzo Sugita
Journal:  Biochem Soc Trans       Date:  2018-02-22       Impact factor: 5.407

6.  Mast cell degranulation impairs pneumococcus clearance in mice via IL-6 dependent and TNF-α independent mechanisms.

Authors:  Jing Yang; Jichao Wang; Xuemei Zhang; Yulan Qiu; Jurong Yan; Si Sun; Yujuan He; Yibing Yin; Wenchun Xu
Journal:  World Allergy Organ J       Date:  2019-04-20       Impact factor: 4.084

Review 7.  Molecular Mechanisms of Mast Cell Activation by Cholesterol-Dependent Cytolysins.

Authors:  Lubica Draberova; Magda Tumova; Petr Draber
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561

8.  Mast Cells Are Activated by Streptococcus pneumoniae In Vitro but Dispensable for the Host Defense Against Pneumococcal Central Nervous System Infection In Vivo.

Authors:  Johanna Fritscher; Daniel Amberger; Susanne Dyckhoff; Jan Philipp Bewersdorf; Ilias Masouris; Stefanie Voelk; Sven Hammerschmidt; Helga Maria Schmetzer; Matthias Klein; Hans-Walter Pfister; Uwe Koedel
Journal:  Front Immunol       Date:  2018-03-19       Impact factor: 7.561

9.  Human mast cells exhibit an individualized pattern of antimicrobial responses.

Authors:  Karen M Garcia-Rodriguez; Rajia Bahri; Clara Sattentau; Ian S Roberts; Anu Goenka; Silvia Bulfone-Paus
Journal:  Immun Inflamm Dis       Date:  2020-03-28

10.  Streptococcal H2O2 inhibits IgE-triggered degranulation of RBL-2H3 mast cell/basophil cell line by inducing cell death.

Authors:  Nobuo Okahashi; Masanobu Nakata; Yujiro Hirose; Hirobumi Morisaki; Hideo Kataoka; Hirotaka Kuwata; Shigetada Kawabata
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.